Our Road Map
1
September 2014
Formed RSAMMD (Registered in 2017)2
November 2014
Partnered with South Africa’s leading neurologists, doctors and professors to form the network and start research programs centered around cannabis.3
January 2016
Helped form, and became a member of the CDCSA and has since been in charge of the Western Medical Desk and the medical side of the cannabis development council.4
March 2016
License to conduct R&D for university cannabis program5
May 2017
Started processing and testing RSAMMD’s first CBD oil.6
June 2017
First cannabis Oil product made available to patients for free7
January 2018
Started obtaining letters of intent from already listed international cannabis companies showing interest for off take and internal industry development and collaboration8
April 2018
Awarded first section 21 license to import pharmaceutical grade medical cannabis. Formed seed bank to gain and preserve genetics.9
May 2018
Awarded section 21 to dispense medical cannabis10
August 2018
Pending application to cultivate THC for export in co-operation with SAIPA, IKS, DAFF and the Health department, empowering the aboriginal indigenous KhoiSan11
December 2018
Issued full R&D license to cultivate and experiment under the provisions of documenting findings and positioning ourselves for full license to cultivate and export. Harvested 100 sq. meters of cannabis cultivated under the provision of an R&D license.12
January 2019
Issued license to dispense through traditional healers and IKS.Started building 500 sq. meter indoor facility with fully controlled & automated systems for propagation, seedlings, mothers and cloning.
13
March 2019
Started a training program with other licensed doctors and scientists looking to gain a deeper understanding of cannabis and the endocannabinoid system.14
June 2019
Harvest, process, test and then destroy crop.15
December 2019
Have R&D license converted into licensing for cultivation and therefor expansion and export.16
January 2020
Become South Africa’s first registered medical cannabis pharmaceutical company to export our product to Canadian, European and Australasian markets.17
March 2020
Commence building stage 1, 100,000 square meters GAP climate controlled greenhouse facility for international offtake.18